Atlas FDA

G5 Mobile Continuous Glucose Monitoring System

FDA premarket approval P120005/S077 · decided 2018-10-11

Approval details

PMA number
P120005
Supplement
S077
Supplement type
Real-Time Process
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
G5 Mobile Continuous Glucose Monitoring System
Generic name
Sensor, glucose, invasive, non-adjunctive
Applicant
Dexcom, Inc.
Date received
2018-08-08
Decision date
2018-10-11
Days to decision
64 days
Decision code
APPR
Product code
PQF
Advisory committee
Clinical Chemistry
Expedited review
No
Location
San Diego, CA
Statement
Approval for minor design changes to the firmware installed on the transmitter component of the Dexcom G5 Continuous Glucose Monitoring System.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Stelo Glucose Biosensor System (K260935)Dexcom, Inc.2026-06-12
Dexcom G7 Continuous Glucose Monitoring System;Dexcom G7 15 Day Continuous Glucose Monitoring System (K261402)Dexcom, Inc.2026-06-08
Stelo Glucose Biosensor System (K261359)Dexcom, Inc.2026-05-21
Dexcom G7 Continuous Glucose Monitoring (CGM) System; Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System (K253737)Dexcom, Inc.2026-02-03
Dexcom G7 Continuous Glucose Monitoring (CGM) System, Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System (K253710)Dexcom, Inc.2025-12-17
Dexcom Smart Basal (K252818)Dexcom, Inc.2025-11-18
Dexcom G7 15 Day Continuous Glucose Monitoring System (K243214)Dexcom, Inc.2025-04-09
Dexcom G7 Continuous Glucose Monitoring System (K240902)Dexcom, Inc.2024-04-23